DK2131845T3 - 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former - Google Patents

5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former

Info

Publication number
DK2131845T3
DK2131845T3 DK08717228.4T DK08717228T DK2131845T3 DK 2131845 T3 DK2131845 T3 DK 2131845T3 DK 08717228 T DK08717228 T DK 08717228T DK 2131845 T3 DK2131845 T3 DK 2131845T3
Authority
DK
Denmark
Prior art keywords
phenyl
polymorphs
morpholin
isoxazole
ylmethyl
Prior art date
Application number
DK08717228.4T
Other languages
Danish (da)
English (en)
Inventor
Martin James Drysdale
Brian William Dymock
Christoph Krell
Michael Mutz
Holger Petersen
Weijia Zheng
Original Assignee
Novartis Ag
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38134307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2131845(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Vernalis R&D Ltd filed Critical Novartis Ag
Application granted granted Critical
Publication of DK2131845T3 publication Critical patent/DK2131845T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK08717228.4T 2007-03-01 2008-02-28 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former DK2131845T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103346 2007-03-01
PCT/EP2008/052443 WO2008104595A1 (en) 2007-03-01 2008-02-28 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

Publications (1)

Publication Number Publication Date
DK2131845T3 true DK2131845T3 (da) 2012-07-16

Family

ID=38134307

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08717228.4T DK2131845T3 (da) 2007-03-01 2008-02-28 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazol-3-carboxylsyre-ethylamid-mesylat, hydrater og polymorfe deraf samt præparater, der omfatter disse former

Country Status (40)

Country Link
US (3) US8163747B2 (enExample)
EP (2) EP2131845B1 (enExample)
JP (1) JP2010520176A (enExample)
KR (1) KR20090122218A (enExample)
CN (2) CN102302500A (enExample)
AR (1) AR065519A1 (enExample)
AT (1) ATE552836T1 (enExample)
AU (1) AU2008220800B2 (enExample)
BR (1) BRPI0807992A2 (enExample)
CA (1) CA2678043A1 (enExample)
CL (1) CL2008000618A1 (enExample)
CO (1) CO6210828A2 (enExample)
CR (1) CR10989A (enExample)
CY (1) CY1113805T1 (enExample)
DK (1) DK2131845T3 (enExample)
DO (1) DOP2009000209A (enExample)
EA (1) EA017075B1 (enExample)
EC (1) ECSP099602A (enExample)
ES (1) ES2384906T3 (enExample)
GE (1) GEP20115309B (enExample)
GT (1) GT200900236A (enExample)
HR (1) HRP20120535T1 (enExample)
IL (1) IL200401A0 (enExample)
MA (1) MA31204B1 (enExample)
MX (1) MX2009009233A (enExample)
NI (1) NI200900161A (enExample)
NZ (1) NZ578854A (enExample)
PA (1) PA8771101A1 (enExample)
PE (1) PE20090166A1 (enExample)
PL (1) PL2131845T3 (enExample)
PT (1) PT2131845E (enExample)
RS (1) RS52351B (enExample)
SI (1) SI2131845T1 (enExample)
SM (1) SMAP200900080A (enExample)
TN (1) TN2009000357A1 (enExample)
TW (1) TW200844102A (enExample)
UA (1) UA101950C2 (enExample)
UY (1) UY30943A1 (enExample)
WO (1) WO2008104595A1 (enExample)
ZA (1) ZA200905417B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
TWI450898B (zh) * 2008-07-04 2014-09-01 Sigma Tau Res Switzerland Sa 具有抗腫瘤活性之芳基異唑化合物
US8309578B2 (en) 2008-11-25 2012-11-13 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
WO2011089234A2 (en) * 2010-01-21 2011-07-28 Aprea Ab Method and composition
CN102753546A (zh) * 2010-02-17 2012-10-24 日东制药株式会社 新型5-元杂环衍生物及其制备方法
KR20120031854A (ko) 2010-09-27 2012-04-04 한국전자통신연구원 시간 및 주파수 특징을 이용하는 음악 음원 분리 장치 및 방법
WO2013015661A2 (en) * 2011-07-28 2013-01-31 Ildong Pharm Co.,Ltd. Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101166749B1 (ko) * 2003-02-11 2012-07-27 베르날리스(캠브리지)리미티드 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
US20060070405A1 (en) * 2004-10-06 2006-04-06 Anheuser-Busch, Inc. Method for the production of amber glass with reduced sulfur-containing emissions
CA2677651A1 (en) 2007-02-15 2008-08-21 Novartis Ag Combinations of therapeutic agents for treating cancer
WO2010069458A1 (de) 2008-12-17 2010-06-24 Merck Patent Gmbh Hexahalochromat(lll)-komplexe

Also Published As

Publication number Publication date
HRP20120535T1 (hr) 2012-07-31
ATE552836T1 (de) 2012-04-15
EP2545921A2 (en) 2013-01-16
GT200900236A (es) 2011-09-14
RS52351B (sr) 2012-12-31
TN2009000357A1 (en) 2010-12-31
EP2545921A3 (en) 2013-04-10
CY1113805T1 (el) 2016-07-27
MA31204B1 (fr) 2010-02-01
EA017075B1 (ru) 2012-09-28
EP2131845B1 (en) 2012-04-11
CO6210828A2 (es) 2010-10-20
KR20090122218A (ko) 2009-11-26
AR065519A1 (es) 2009-06-10
SI2131845T1 (sl) 2013-02-28
CA2678043A1 (en) 2008-09-04
US20130296556A1 (en) 2013-11-07
AU2008220800A1 (en) 2008-09-04
JP2010520176A (ja) 2010-06-10
PL2131845T3 (pl) 2012-09-28
UA101950C2 (ru) 2013-05-27
ES2384906T3 (es) 2012-07-13
TW200844102A (en) 2008-11-16
HK1139073A1 (en) 2010-09-10
NI200900161A (es) 2010-07-27
UY30943A1 (es) 2008-10-31
PT2131845E (pt) 2012-07-10
PE20090166A1 (es) 2009-03-14
US8163747B2 (en) 2012-04-24
EA200901141A1 (ru) 2010-04-30
ECSP099602A (es) 2009-12-28
BRPI0807992A2 (pt) 2014-06-17
NZ578854A (en) 2012-03-30
CN102302500A (zh) 2012-01-04
DOP2009000209A (es) 2009-09-15
MX2009009233A (es) 2010-06-02
GEP20115309B (en) 2011-10-25
CL2008000618A1 (es) 2008-09-12
SMAP200900080A (it) 2010-01-19
PA8771101A1 (es) 2009-02-09
IL200401A0 (en) 2010-04-29
US20120172592A1 (en) 2012-07-05
EP2131845A1 (en) 2009-12-16
US8487095B2 (en) 2013-07-16
US20100093732A1 (en) 2010-04-15
CN101636162A (zh) 2010-01-27
WO2008104595A1 (en) 2008-09-04
ZA200905417B (en) 2010-05-26
AU2008220800B2 (en) 2012-02-16
CR10989A (es) 2010-03-01

Similar Documents

Publication Publication Date Title
HUS2300029I1 (hu) Fungicid vegyületek és keverékek
SI2131845T1 (sl) Mesilat etilamida 5-(2,4-dihidroksi-5-izopropil-fenil)-4-(4-morfolin- 4-ilmetilfenil)-izoksazol-3-karboksilne kisline, hidrati in polimorfi le-tega in formulacije, ki vsebujejo te oblike
DK2200985T3 (da) 1,3-Disubstituerede 4-(aryl--X-phenyl)-1H-pyridin-2-oner
EP2268211A4 (en) INSTRUMENT FOR MINIMUM ACCESS
DE602006016303D1 (de) 3,4-dihydro-2H-benzoÄ1,4Üoxazin- und 3,4-dihydro-2H-benzoÄ1,4Üthiazin-VERBINDUNGEN ALS ALPHA2C-ADRENOREZEPTOR-ANTAGONISTEN
FR2932492B1 (fr) Compositions a base d'hydrofluoroolefines
FR2932493B1 (fr) Compositions a base d'hydrofluoroolefines
DK2010501T3 (da) Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse
DK3473101T3 (da) Isoxazolinsammensætninger og deres anvendelse som antiparasitik for feliner
FR2932494B1 (fr) Compositions a base d'hydrofluoroolefines
ATE462444T1 (de) Immunogene zusammensetzung
EP2418959A4 (en) NEW FOOD COMPOSITIONS FROM MICRO ALGAE
DK2527714T3 (da) Modificeret latexfriktionsformindsker
ATE460839T1 (de) Herbizide zusammensetzung
BRPI0806689A2 (pt) Compostos químicos 637
EP2381771A4 (en) AUXINHERBIZIDZUSAMMENSETZUNG
DK1881377T3 (da) Skydelukker og tonertilførselsapparat, der omfatter skydelukkeren
LT3210610T (lt) Kompozicijos, turinčios triazonų ir geležies
DK2053921T3 (da) Ny antifungal sammensætning
EP2434892A4 (en) ANTIFUNGAL AZOLIC COMPOSITIONS
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DE602006010196D1 (de) Zementzusammensetzungen mit umweltverträglichen entschäumern und verwendungsverfahren
PL2171101T3 (pl) Piec szybowy i sposób eksploatacji pieca szybowego
EP2382224A4 (en) METALLHYDRAZIDMATERIALIEN
DK1698668T3 (da) Stuetemperatur-hærdelige organopolysiloxansammensætninger